FANTACUZZI, MARIALUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 5.127
EU - Europa 3.397
AS - Asia 3.256
Continente sconosciuto - Info sul continente non disponibili 573
SA - Sud America 337
AF - Africa 55
OC - Oceania 2
Totale 12.747
Nazione #
US - Stati Uniti d'America 4.959
SG - Singapore 1.225
CN - Cina 883
IT - Italia 830
IE - Irlanda 413
TR - Turchia 385
UA - Ucraina 351
SE - Svezia 349
RU - Federazione Russa 314
VN - Vietnam 296
BR - Brasile 277
FR - Francia 256
GB - Regno Unito 251
IN - India 234
DE - Germania 198
PL - Polonia 126
FI - Finlandia 104
CA - Canada 101
HK - Hong Kong 49
ES - Italia 44
BD - Bangladesh 40
AT - Austria 34
MX - Messico 30
NL - Olanda 29
JP - Giappone 28
CZ - Repubblica Ceca 24
ZA - Sudafrica 22
BE - Belgio 21
ID - Indonesia 16
LT - Lituania 16
AR - Argentina 14
PK - Pakistan 14
PT - Portogallo 14
VE - Venezuela 14
IQ - Iraq 10
KR - Corea 10
JM - Giamaica 9
PH - Filippine 9
CL - Cile 8
SA - Arabia Saudita 8
CO - Colombia 7
MY - Malesia 7
CR - Costa Rica 6
EC - Ecuador 6
MA - Marocco 6
TW - Taiwan 6
CH - Svizzera 5
DZ - Algeria 5
GR - Grecia 5
HN - Honduras 5
HR - Croazia 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
PE - Perù 4
TT - Trinidad e Tobago 4
AL - Albania 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IL - Israele 3
JO - Giordania 3
PY - Paraguay 3
UY - Uruguay 3
YE - Yemen 3
AU - Australia 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BZ - Belize 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 12.176
Città #
Singapore 915
San Jose 580
Chandler 501
Jacksonville 429
Ashburn 409
Dublin 407
Dallas 262
Izmir 244
Beijing 227
Dearborn 210
Chieti 209
Princeton 169
Council Bluffs 152
Southend 148
Nanjing 128
Los Angeles 118
Santa Clara 117
The Dalles 117
Ho Chi Minh City 101
Kraków 89
Cambridge 82
Ann Arbor 79
New York 77
Wilmington 69
Nanchang 63
Hanoi 60
Munich 55
Altamura 49
Tongling 48
Hong Kong 43
Moscow 42
Buffalo 37
São Paulo 35
Warsaw 35
Pescara 34
Boardman 33
Hebei 31
Orem 31
Bosa 30
Shenyang 30
Teramo 30
Atlanta 28
Helsinki 27
Redondo Beach 27
Da Nang 25
Denver 25
Jiaxing 25
Milan 24
Brno 23
Brooklyn 23
Jinan 23
Rome 23
Vienna 23
Chennai 22
Kunming 22
Stockholm 22
Washington 22
Brussels 21
Columbus 21
Houston 21
Montreal 21
Toronto 21
Chicago 20
London 20
Ottawa 20
Tianjin 20
Tokyo 20
Changsha 19
Kocaeli 17
Hefei 16
Amsterdam 15
Johannesburg 15
Phoenix 15
Poplar 15
Haiphong 14
San Francisco 14
Turku 14
Manchester 13
Woodbridge 13
Hangzhou 12
Mexico City 12
Nuremberg 11
Ankara 10
Bologna 10
Falls Church 10
Norwalk 10
Augusta 9
Biên Hòa 9
Ningbo 9
Seattle 9
Dong Ket 8
Porto 8
Redwood City 8
Rio de Janeiro 8
Shanghai 8
Zhengzhou 8
Belo Horizonte 7
Changchun 7
Como 7
Frankfurt am Main 7
Totale 7.481
Nome #
Anticancer Activity of Stilbene-Based Derivatives 199
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 196
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 194
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 192
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 179
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 176
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 175
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 174
Recent developments of amidine-like compounds as selective NOS inhibitors 173
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 170
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 168
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 168
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 165
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 163
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 163
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 162
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 160
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 160
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 158
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 158
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 154
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 152
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 151
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 147
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 147
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 147
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 147
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 144
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 143
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 141
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 141
Amidine-Based Compounds Affecting L-Arginine Metabolism 139
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 138
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 138
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 137
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 136
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 136
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 134
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 134
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 134
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 132
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 131
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 131
Structural development studies of PPARs ligands based on tyrosine scaffold 131
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 128
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 128
null 128
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 127
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 127
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 126
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 125
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 125
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 124
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 122
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 121
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 120
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 119
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 118
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 117
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 116
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 114
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 114
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 113
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 112
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 112
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 112
Methods to Evaluate the Activity of Nitric Oxide Synthase 111
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 110
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 110
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 110
Antiviral Peptides as Anti-Influenza Agents 110
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 107
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 107
Separazione enantiomerica di analoghi chirali dell'acido clofibrico mediante elettroforesi capillare 106
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 106
PPAR Ligands Containing Stilbene Scaffold 106
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 105
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 105
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 100
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 99
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 97
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection 96
N-Acylsulfonylamides as a new class of PPARa antagonists 93
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 92
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 91
Enantiomeric separation of some chiral analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 90
Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents 89
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 89
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 87
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 85
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer 83
Development of CDK4/6 Inhibitors: A Five Years Update 83
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 83
Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery 81
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 70
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 67
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 66
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study 65
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy 60
Totale 12.673
Categoria #
all - tutte 49.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022588 0 0 22 95 54 22 23 52 97 20 70 133
2022/20231.441 103 202 108 136 133 305 71 110 178 17 52 26
2023/2024693 51 21 61 14 43 216 166 10 4 30 9 68
2024/20251.645 73 303 268 21 38 90 64 96 161 73 237 221
2025/20264.036 309 129 444 514 478 218 709 270 396 316 192 61
2026/2027371 112 180 79 0 0 0 0 0 0 0 0 0
Totale 12.747